Impact of AI on the Drug Discovery Process
On average, the drug discovery process is a 10-17 year process, with less than 10% probability of success, and costs $2.6B. By introducing AI to the workflow, enterprises can not only shorten the process to 7 – 12 years with a higher than 60% probability of success but also reduce the cost by 22% – 35%.
Target Discovery
1 – 2 YEARS WITH AI
- Omics data analysis
- In vitro function validation
- In vivo validation (ex. knockouts)
- Literature search
AI USE CASES:
- Drug target identification
- Signaling and metabolic pathway predictions
- Literature mining
Discovery & Screening
0.5 YEARS WITH AI
- Discovery & Screening
- Combinatorial chemistry
- Structure-based drug design
- High throughput in vitro screening
- Ex vivo and in vivo screening
AI USE CASES:
- Test library selection
- Screening optimization (siRNA efficiency prediction)
- Drug repurposing
Lead Optimization
1-2 YEARS WITH AI
- Traditional medicinal chemistry
- Rational drug design
AI USE CASES:
- Chemical design
- Interaction prediction
- Manufacturability
- Pricing prediction
- Drug economics
ADMET (Absorption, Distribution, Metabolism, and Excretion – Toxicity)
0.5-1 YEARS WITH AI
- Bioavailability & systemic exposure
- Formulation
AI USE CASES:
- Chemical property prediction
- Pathway simulation
- Pathology imaging
- Efficacy prediction
Why AI in Drug Discovery?
Screening made more efficient
Identifying CMC issues before they happen in drug production and manufacturing reduces costs and helps optimize the products. Large previous screening data in your laboratory allows AI to learn optimal conditions. Narrowing conditions to test minimizes the time and cost to complete the screening.
Read up on our latest blogs in the field of Bioinformatics
AI Dynamics applied LRP to a cancer classification model, built on gene expression data, to identify a set of genes important for classifying cancer patients.